IndraLab

Statements

USP22 inhibits cisplatin. 8 / 8
| 8
reach
"In addition, the cisplatin sensitivity in cisplatin resistant A549 and CDDP cells was restored by USP22 inhibition in vivo and vitro."
28567015
reach
"The cisplatin sensitivity in cisplatin resistant A549 and CDDP cells was restored by USP22 inhibition in vivo and vitro."
28567015
reach
"The Cisplatin Sensitivity in Cisplatin Resistant A549 and CDDP Cells Was Restored by USP22 Inhibition."
28567015
reach
"These results suggest that inhibiting USP22 expression enhanced cisplatin sensitivity in lung adenocarcinoma by downregulation of Sirt1 and gammaH2AX in vivo."
28567015
reach
"Furthermore, USP22 knockout significantly impaired non homologous DNA damage repair capacity, enhanced cisplatin and irradiation induced apoptosis in these cells."
31842906
reach
"These results indicate that the cisplatin sensitivity in cisplatin resistant A549 and CDDP cells was restored by USP22 inhibition."
28567015
reach
"Silencing USP22 can inhibit the Wnt/β-catenin pathway to reduce cell stemness and enhance the sensitivity of PC cells to cisplatin."
35623308
reach
"Inhibiting USP22 Expression Enhanced Cisplatin Sensitivity in Cisplatin Resistant A549 and CDDP Cell Nude Mouse Xenografts."
28567015